A carregar...
Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight
Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are newly approved class of oral anti-diabetic drugs, in the treatment of type 2 diabetes, which reduces blood glucose through glucouresis via the kidney, independent, and irrespective of available pancreatic beta-cells. Studies conducted across t...
Na minha lista:
| Publicado no: | Indian J Endocrinol Metab |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673799/ https://ncbi.nlm.nih.gov/pubmed/26693421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.167554 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|